Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1286.6 Million | USD 2765.96 Million | 8.1% | 2024 |
The global digital pathology market size was worth around USD 1286.6 Million in 2024 and is predicted to grow to around USD 2765.96 Million by 2034 with a compound annual growth rate (CAGR) of roughly 8.1% between 2025 and 2034. The report analyzes the global digital pathology market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital pathology industry.
Digital Pathology enables laboratories to provide results of tests and diagnoses via digital means and is gaining popularity as advancements in healthcare technology are taking over the healthcare infrastructure across the world. The COVID-19 pandemic resulted in a hike of demand for Digital Pathology as they were compatible with the social distancing and lockdown norms.
Increasing technological proliferation, rapid advancements in Digital Pathology, increasing demand for quality treatment and diagnostics, increasing prevalence of deadly diseases, and rising demand for efficient laboratory testing are some major factors that propel the Digital Pathology market potential over the forecast period.
However, high costs and lack of skilled professionals will hamper the Digital Pathology market growth through 2028 and are expected to slow down the overall market.
Increasing Demand for Lab Efficiency
Technological proliferation has increased in all aspects of life and even in labs, digital pathology is helping cut costs and increasing efficiency and productivity. Faster pathology results can facilitate better diagnostic and better treatment opportunities and these factors are subsequently driving the demand for the Digital Pathology market growth through the forecast period. The COVID-19 pandemic further bolstered the demand for Digital Pathology as it was deployed to contain the infection spread among healthcare professionals under lockdown restrictions.
High Costs to Hinder market
Digital Pathology solutions are costly and this is a major factor that restrains the adoption of these systems in healthcare infrastructure across the globe. This factor will major drag down growth in emerging economies like India and China where spending potential is less and hence will slow down the overall growth of the Digital Pathology market over the forecast period. Apart from this lack of trained individuals to operate these advanced systems will also have a restraining effect on the Digital Pathology market through 2028.
The global Digital Pathology market is segregated based on type, product type, application, end user, and region.
By product, the market is divided into Scanners, Software, Communication Systems, and Storage Systems. The scanners segment is anticipated to emerge as the most lucrative one over the forecast period. These devices are expensive and essential in digital pathology hence their value share is high in the global Digital Pathology marketplace and this stance will be maintained over the forecast period as well.
On the basis of Type, the global digital pathology market is bifurcated into Human Pathology, Veterinary Pathology.
By Application, the Digital Pathology market is segmented into Drug Discovery, Disease Diagnosis, Teleconsultation, and Training & Education. The drug discovery segment is anticipated to give a dominant outlook over the forecast period. Rising demand for drugs and increasing research and development activity across the world for new pharmaceuticals are expected to be prominent factors driving demand for this segment through 2034.
In terms of End User, the global digital pathology market is categorized into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, Academic & Research Institutes.
Report Attributes | Report Details |
---|---|
Report Name | Digital Pathology Market |
Market Size in 2024 | USD 1286.6 Million |
Market Forecast in 2034 | USD 2765.96 Million |
Growth Rate | CAGR of 8.1% |
Number of Pages | 177 |
Key Companies Covered | Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain)., and others. |
Segments Covered | By Product, By Type, By Application, By End User, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Owing to the presence of a developed healthcare infrastructure the Digital Pathology market in North America is expected to hold a dominant outlook over the forecast period. Increasing spending on research and development activities in this region is expected to be a prominent driver through 2028. Rising support from the government, increasing adoption of technology in healthcare, favorable reimbursement policies, and increasing demand for better diagnostics and treatment are other factors that will drive the Digital Pathology market growth over the forecast period. The Unites States is anticipated to be the most lucrative country in this region through 2028.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the digital pathology market on a global and regional basis.
The global digital pathology market is dominated by players like:
The global digital pathology market is segmented as follows;
By Product
By Type
By Application
By End User
By Region
FrequentlyAsked Questions
North America & Europe is expected to dominate the digital pathology market over the forecast period.
Leading players in the global digital pathology market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain)., among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed